ascendis pharma glp-1 receptor agonist weight management diabetes treatments Novo inks deal to develop long-acting GLP-1, other metabolic drugs Emerging Role of GLP-1 Receptor
Description
Thus, these trials are not thoroughly discussed in this review
2023;12(18) doi: 10.3390/jcm12185915
Cell Metab 17, 819837 (2013)
Depending on patient-specific factors and associated risks, anesthesia providers could consider treating these patients as if they have a full stomach
Eligibility for a GLP-1 is based on a thorough evaluation of medical history, eating behavior, lab work, and insurance coverage
16(9): e68390
